Home / Inspections / 1131381

FDA Inspection 1131381 — Janssen Pharmaceuticals, Inc

Janssen Pharmaceuticals, Inc — FEI 2242843

The FDA completed an inspection of Janssen Pharmaceuticals, Inc on September 14, 2020 in Titusville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 14, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Titusville, NJ (United States)

Facility

Other inspections at this facility

  • 1271223 (NAI Thu Aug 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1229931 (VAI Fri Sep 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1131617 (NAI Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1031605 (NAI Fri Oct 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 923153 (NAI Wed Apr 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources